The increasing demand for specific immunological study and therapeutic design has spurred significant progress in recombinant Recombinant Human EGF cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression platforms, including prokaryotic hosts, higher cell lines,